dosage adjustment daunorubicin hydrochloride daunorubicin citrate (liposomal) *in renal impairment:...
DESCRIPTION
Patient Information:::::::Daunorubicin HCl Only administered IV During therapy do not use alcohol, aspirin-containing products and/or OTC medications without consulting prescriber. It is important to maintain adequate nutrition & hydration (2-3L/day of fluids unless instructed to restrict fluid intake)during therapy, frequent small meals may help. Patient may experience nausea & vomiting (frequent small meals,frequent mouth care, sucking lozenges, or chewing gum may help) You may experience loss of hair(reversible),more susceptible to infection Urine may turn Red(normal) Yoghurt or butter milk may help reduce diarrhea.TRANSCRIPT
Dosage adjustment
Daunorubicin Hydrochloride
Daunorubicin Citrate (Liposomal)
*in Renal impairment:a)CLcr <10ml/min.
b)Scr > 3mg/dl
*in Hepatic impairment:a)Serum Bilirubin 1.2-3 mg/dl or AST 60-180 int. units
b)Serum Bilirubin 3.1-5mg/dl or AST >180 int. units
c)Serum Bilirubin >5mg/dl
Administer 75% of normal dose.
Omit use
Reduce dose to 75%
Reduce dose to 50%
Dosage Adjustment
Doxorubicin Epirubicin Idarubicin Mitoxantrone
*renal impairment:a)Mild to moderate renal failureb) Clcr.<10ml/min
Not required.
administer 75% of normal dose.
Hemodialysis: supplemental dose is not necessary
Severe (Scr >5mg/dl) lower doses should be considered.
Serum cr ≥ 2mg/dladminister 75%of dose
In hemo/peritoneal dialysis: significant drug removal is unlikely based on physicochemical characteristics.
Safety & Efficacy have not established.
Hemo/peritoneal dialysis: supplemental dose is not necessary.
Elderly: Cl is decreased in elderly pt’s; use with caution.
*hepatic impairmenta)Bilirubin (1.2-3mg/dl)
b) Bil.3.1-5mg/dl
c) >5mg/dl Do not administer
1.5-5mg/dl or AST 60-180 int. units/l administer 50% of normal dose.
Do not administer
Official dosage adj. recommended have not been established.
Moderate dysfunction (bil1.5-3mg/dl):some clinicians recommend a 50%dosage reduction.
Severe dysfunction(bil. >3 mg/dl)may require a dosage adj. to 8mg/m2,some clinicians recommend a dose reduction to 25% of dose.
administer 50% of dose
admin. 25% of dose.
Patient Information:::::::Daunorubicin HCl
Only administered IV During therapy do not use alcohol, aspirin-containing products and/or OTC medications without consulting prescriber.It is important to maintain adequate nutrition & hydration (2-3L/day of fluids unless instructed to restrict fluid intake)during therapy, frequent small meals may help.Patient may experience nausea & vomiting (frequent small meals ,frequent mouth care, sucking lozenges, or chewing gum may help)You may experience loss of hair(reversible),more susceptible to infectionUrine may turn Red(normal)Yoghurt or butter milk may help reduce diarrhea.
Patient Info::::::Mitoxantrone
Urine may turn blue-green for 24hrs after infusion & the whites of your eyes may have a blue-green tinge ; this is normal.
Drug Interactions
Cyclosporine Hematologic toxicity.
Cyclophosphamide cardiac toxicity(myocardium cell damage)
Doxorubicin
Paclitaxel, streptozocin, Mercaptopurine, Verapamil & high dose of progesterone.
Toxicity
Ppt with heaprin & fluorouracil
Drug Interactions
Vaccines
Taxane derivati
ve
Natalizumab&Trastuzum
ab